American Association for Cancer Research
Browse
10780432ccr132177-sup-relatedarticle.html (0.9 kB)

Related Article from It Takes Two to Tango: Dual Inhibition of PI3K and MAPK in Rhabdomyosarcoma

Download (0.9 kB)
dataset
posted on 2023-03-31, 17:31 authored by Arman Jahangiri, William A. Weiss
Related Article from It Takes Two to Tango: Dual Inhibition of PI3K and MAPK in Rhabdomyosarcoma

History

ARTICLE ABSTRACT

The PI3K/AKT/mTOR and RAS/RAF/MAPK pathways play essential roles in rhabdomyosarcoma. Singular targeting of each pathway is ineffective due to extensive cross-talk and compensatory feedback between these two pathways. Dual blockade with inhibitors of PI3K and MAPK in combination synergistically inhibits growth of rhabdomyosarcoma both in vitro and in vivo. Clin Cancer Res; 19(21); 5811–3. ©2013 AACR.

Usage metrics

    Clinical Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC